Gen House Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • IPO Registration

  • Employees
  • 31

Employees

  • Latest Deal Type
  • IPO
  • (Announced)

  • Investors
  • 23

Gen House General Information

Description

Developer of original anti-tumor drugs designed for anti-cancer therapeutics. The company develops new tumor immunotherapy drugs and clinical detection methods based on precision medicine, enabling patients to have better treatment through the combined drug delivery of large molecules and small molecules.

Contact Information

Formerly Known As
Suzhou Qinhao Pharmaceutical Research and Development Co., Ltd.
Ownership Status
In IPO Registration
Financing Status
Venture Capital-Backed
Corporate Office
  • Unit 401, Building 8, Area A, Phase III Biomedical Industrial Park
  • Number 1 Xinze Road, Suzhou Industrial Park, Suzhou Area of China Pilot Free Trade Zone
  • Suzhou, Jiangsu 215100
  • China
+86 0512
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Unit 401, Building 8, Area A, Phase III Biomedical Industrial Park
  • Number 1 Xinze Road, Suzhou Industrial Park, Suzhou Area of China Pilot Free Trade Zone
  • Suzhou, Jiangsu 215100
  • China
+86 0512

Gen House Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Gen House Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. IPO 23-Jan-2026 Announced Generating Revenue
11. Later Stage VC (Series BB) 13-Jan-2026 Completed Generating Revenue
10. Later Stage VC (Series B3) 22-Oct-2025 Completed Generating Revenue
9. Later Stage VC (Series B2) 08-Jul-2024 Completed Generating Revenue
8. Secondary Transaction - Private 08-Oct-2023 Completed Generating Revenue
7. Later Stage VC (Series B1) 21-Mar-2023 Completed Generating Revenue
6. Secondary Transaction - Private 22-Aug-2022 Completed Generating Revenue
5. Later Stage VC (Series B) 13-Feb-2022 Completed Generating Revenue
4. Later Stage VC (Series A) 08-Jun-2021 $29.7M $34.6M Completed Generating Revenue
3. Later Stage VC 25-Jul-2020 $2.86M $4.92M Completed Generating Revenue
To view Gen House’s complete valuation and funding history, request access »

Gen House Patents

Gen House Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026153498-A1 Amide compound, pharmaceutical composition comprising same, and use thereof Pending 17-Jan-2025
WO-2025242126-A1 Pharmaceutical composition and use thereof Pending 22-May-2024
WO-2025201332-A1 Oxadiazole compound, pharmaceutical composition comprising same, and use thereof Pending 26-Mar-2024
AU-2024410908-A1 Fused ring compound, pharmaceutical composition containing same and use thereof Pending 29-Dec-2023
EP-4834908-A1 Fused ring compound, pharmaceutical composition containing same and use thereof Pending 29-Dec-2023 A61K31/519
To view Gen House’s complete patent history, request access »

Gen House Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Gen House Investors (23)

Investor Name Investor Type Holding Investor Since Participating Rounds
BOHE Angel Fund Venture Capital Minority
Genova Corporation Minority
Guangzhou Industrial Investment Holding Group Government Minority
Vivatec Corporation Minority
YuanBio Venture Capital Venture Capital Minority
You’re viewing 5 of 23 investors. Get the full list »

Gen House FAQs

  • When was Gen House founded?

    Gen House was founded in 2014.

  • Where is Gen House headquartered?

    Gen House is headquartered in Suzhou, China.

  • What is the size of Gen House?

    Gen House has 31 total employees.

  • What industry is Gen House in?

    Gen House’s primary industry is Drug Discovery.

  • Is Gen House a private or public company?

    Gen House is a Private company.

  • What is Gen House’s current revenue?

    The current revenue for Gen House is .

  • How much funding has Gen House raised over time?

    Gen House has raised $121M.

  • Who are Gen House’s investors?

    BOHE Angel Fund, Genova, Guangzhou Industrial Investment Holding Group, Vivatec, and YuanBio Venture Capital are 5 of 23 investors who have invested in Gen House.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process